Dimerization of cell surface receptors in signal transduction

Introduction Cell growth, differentiation, migration, and apoptosis are in part regulated by polypeptide growth factors or cytokines. As these factors are unable to pass the hydrophobic cell membrane, a fundamental question is how they transduce their signals into the cell. Growth factors and cytokines exert their effects via binding to cell surface receptors; results obtained during recent years have given ample evidence that such receptors often are activated by ligand-induced dimerization or oligomerization. Moreover, the elucidation of intracellular signal transduction pathways have revealed that the activity of several components in these pathways are also regulated by dimerization. For instance, certain of the cytoplasmic signal transduction molecules dimerize after activation, and the active form of transcription factors are often dimers. It thus appears that dimerization is a mechanism of general applicability for the regulation of signal transduction. This review focuses on the role of dimerization of cell surface receptors in signal transduction. Dimerization or oligomerization have been shown to occur after binding of several polypeptide hormones, cytokines, growth factors, or growth inhibitors to their receptors. Examples include protein-tyrosine kinase receptors, cytokine receptors, antigen receptors, receptors for tumor necrosis factor (TNF) and related factors, and serine/threonine kinase receptors (Figure 1; Table 1). There are, however, many variations on the theme, as will be discussed below.

[1]  M. Erdos,et al.  Heterodimerization of the IL-2 receptor β- and γ-chain cytoplasmic domains is required for signalling , 1994, Nature.

[2]  Dan R. Littman,et al.  Signal transduction by lymphocyte antigen receptors , 1994, Cell.

[3]  A. Wilks,et al.  JAK protein tyrosine kinases: their role in cytokine signalling. , 1994, Trends in cell biology.

[4]  M. Sliwkowski,et al.  Coexpression of erbB2 and erbB3 proteins reconstitutes a high affinity receptor for heregulin. , 1994, The Journal of biological chemistry.

[5]  H. Lodish,et al.  The types II and III transforming growth factor-beta receptors form homo-oligomers , 1994, The Journal of cell biology.

[6]  Xin-Yuan Fu,et al.  Transcription factor p91 interacts with the epidermal growth factor receptor and mediates activation of the c-fos gene promoter , 1993, Cell.

[7]  S. Harrison,et al.  Recognition of a high-affinity phosphotyrosyl peptide by the Src homology-2 domain of p56lck , 1993, Nature.

[8]  L. Naldini,et al.  The tyrosine kinase encoded by the MET proto-oncogene is activated by autophosphorylation , 1991, Molecular and cellular biology.

[9]  M. Aguet,et al.  Molecular cloning and expression of the human interferon-γ receptor , 1988, Cell.

[10]  G. Yancopoulos,et al.  Ciliary neurotrophic factor/leukemia inhibitory factor/interleukin 6/oncostatin M family of cytokines induces tyrosine phosphorylation of a common set of proteins overlapping those induced by other cytokines and growth factors. , 1994, The Journal of biological chemistry.

[11]  J. Darnell,et al.  Stat3 and Stat4: members of the family of signal transducers and activators of transcription. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[12]  M. R. Clark,et al.  Analysis of Ig‐alpha‐tyrosine kinase interaction reveals two levels of binding specificity and tyrosine phosphorylated Ig‐alpha stimulation of Fyn activity. , 1994, The EMBO journal.

[13]  J. Darnell,et al.  A single phosphotyrosine residue of Stat91 required for gene activation by interferon-gamma. , 1993, Science.

[14]  K. Miyazono,et al.  Receptors for transforming growth factor-beta. , 1994, Advances in immunology.

[15]  J. Cambier,et al.  The hetero-oligomeric antigen receptor complex and its coupling to cytoplasmic effectors. , 1994, Current opinion in genetics & development.

[16]  D. Levy,et al.  Ras-independent growth factor signaling by transcription factor tyrosine phosphorylation. , 1993, Science.

[17]  C. Wernstedt,et al.  A unique autophosphorylation site in the platelet-derived growth factor alpha receptor from a heterodimeric receptor complex. , 1994, European journal of biochemistry.

[18]  M. Pierotti,et al.  TRK-T1 is a novel oncogene formed by the fusion of TPR and TRK genes in human papillary thyroid carcinomas. , 1992, Oncogene.

[19]  M. Barbacid,et al.  A human oncogene formed by the fusion of truncated tropomyosin and protein tyrosine kinase sequences , 1986, Nature.

[20]  R. Derynck,et al.  Homomeric interactions between type II transforming growth factor-beta receptors. , 1994, The Journal of biological chemistry.

[21]  P. Distefano,et al.  Released form of CNTF receptor alpha component as a soluble mediator of CNTF responses. , 1993, Science.

[22]  Jeffrey L. Wrana,et al.  Mechanism of activation of the TGF-β receptor , 1994, Nature.

[23]  J. Darnell,et al.  Interferon activation of the transcription factor Stat91 involves dimerization through SH2-phosphotyrosyl peptide interactions , 1994, Cell.

[24]  T. Pawson SH2 and SH3 domains , 1992, Current Biology.

[25]  Arthur Weiss,et al.  The cytoplasmic domain of the T cell receptor ζ chain is sufficient to couple to receptor-associated signal transduction pathways , 1991, Cell.

[26]  Comeau,et al.  The IL-6 signal transducer, gp130: an oncostatin M receptor and affinity converter for the LIF receptor. , 1992, Science.

[27]  K. Yasukawa,et al.  IL-6-induced homodimerization of gp130 and associated activation of a tyrosine kinase. , 1993, Science.

[28]  O. Silvennoinen,et al.  Signaling by the cytokine receptor superfamily: JAKs and STATs. , 1994, Trends in biochemical sciences.

[29]  R. Klausner,et al.  Activation of T cells by a tyrosine kinase activation domain in the cytoplasmic tail of CD3 epsilon. , 1992, Science.

[30]  Terry Farrah,et al.  The TNF receptor superfamily of cellular and viral proteins: Activation, costimulation, and death , 1994, Cell.

[31]  Jeffrey L. Wrana,et al.  TGFβ signals through a heteromeric protein kinase receptor complex , 1992, Cell.

[32]  H. Holtmann,et al.  Antibodies to a soluble form of a tumor necrosis factor (TNF) receptor have TNF-like activity. , 1990, The Journal of biological chemistry.

[33]  A. Dunn,et al.  Functional and biochemical association of Hck with the LIF/IL‐6 receptor signal transducing subunit gp130 in embryonic stem cells. , 1994, The EMBO journal.

[34]  J. Schlessinger,et al.  Regulation of signal transduction and signal diversity by receptor oligomerization. , 1994, Trends in biochemical sciences.

[35]  L. Cantley,et al.  A neu acquaintance for ErbB3 and ErbB4: A role for receptor heterodimerization in growth signaling , 1994, Cell.

[36]  Joseph Schlessinger,et al.  Signal transduction by receptors with tyrosine kinase activity , 1990, Cell.

[37]  W. Dougall,et al.  Heterodimerization of epidermal growth factor receptor and wild-type or kinase-deficient Neu: a mechanism of interreceptor kinase activation and transphosphorylation. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[38]  G. Stark,et al.  Complementation by the protein tyrosine kinase JAK2 of a mutant cell line defective in the interferon-& gamma; signal transduction pathway , 1993, Nature.

[39]  J. Massagué,et al.  The TGF-β family and its composite receptors , 1994 .

[40]  D. Goeddel,et al.  Rational design of potent antagonists to the human growth hormone receptor. , 1992, Science.

[41]  C. Schindler Cytokine signal transduction. , 1995, Receptor.

[42]  M. Aguet,et al.  Molecular Cloning and Expression of the Human Interferon-y Receptor , 1988 .

[43]  B. Cohen,et al.  The human interferon α β receptor: Characterization and molecular cloning , 1994, Cell.

[44]  T. Kishimoto,et al.  Cytokine receptors and signal transduction , 1992, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[45]  K. Yasukawa,et al.  Critical cytoplasmic region of the interleukin 6 signal transducer gp130 is conserved in the cytokine receptor family. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[46]  P. Kanakaraj,et al.  Ligand-induced interaction between alpha- and beta-type platelet-derived growth factor (PDGF) receptors: role of receptor heterodimers in kinase activation. , 1991, Biochemistry.

[47]  M. Aguet,et al.  A novel member of the interferon receptor family complements functionality of the murine interferon γ receptor in human cells , 1994, Cell.

[48]  H. Lodish,et al.  Homodimerization and constitutive activation of the erythropoietin receptor. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[49]  M. White,et al.  The IRS-1 signaling system. , 1994, Trends in biochemical sciences.

[50]  W. Sebald,et al.  Conversion of human interleukin‐4 into a high affinity antagonist by a single amino acid replacement. , 1992, The EMBO journal.

[51]  S. Pestka,et al.  Identification and sequence of an accessory factor required for activation of the human interferon γ receptor , 1994, Cell.

[52]  B. Nelson,et al.  Cytoplasmic domains of the interleukin-2 receptor β and γ chains mediate the signal for T-cell proliferation , 1994, Nature.

[53]  G. Rodrigues,et al.  Oncogenic activation of tyrosine kinases. , 1994, Current opinion in genetics & development.

[54]  J. Bazan Emerging families of cytokines and receptors , 1993, Current Biology.

[55]  Takamune Takahashi,et al.  Molecular cloning of rat JAK3, a novel member of the JAK family of protein tyrosine kinases , 1994, FEBS letters.

[56]  K. Clauser,et al.  Dimerization of the extracellular domain of the human growth hormone receptor by a single hormone molecule. , 1991, Science.

[57]  S. Nagata,et al.  Growth and differentiation signals mediated by different regions in the cytoplasmic domain of granulocyte colony-stimulating factor receptor , 1993, Cell.

[58]  M. Ultsch,et al.  Human growth hormone and extracellular domain of its receptor: crystal structure of the complex. , 1992, Science.

[59]  D. Banner,et al.  Crystal structure of the soluble human 55 kd TNF receptor-human TNFβ complex: Implications for TNF receptor activation , 1993, Cell.

[60]  M. Reth Antigen receptor tail clue , 1989, Nature.

[61]  C. Begley,et al.  Cloning of a murine IL‐11 receptor alpha‐chain; requirement for gp130 for high affinity binding and signal transduction. , 1994, The EMBO journal.

[62]  J. Johnston,et al.  Interaction of IL-2R beta and gamma c chains with Jak1 and Jak3: implications for XSCID and XCID. , 1994, Science.

[63]  K. Siddle,et al.  Immunological relationships between receptors for insulin and insulin-like growth factor I. Evidence for structural heterogeneity of insulin-like growth factor I receptors involving hybrids with insulin receptors. , 1989, The Biochemical journal.

[64]  J. Ritz,et al.  Activation of a novel human transforming gene, ret, by DNA rearrangement , 1985, Cell.

[65]  O. Silvennoinen,et al.  Functional activation of Jak1 and Jak3 by selective association with IL-2 receptor subunits. , 1994, Science.

[66]  D. Baltimore,et al.  Modular binding domains in signal transduction proteins , 1995, Cell.

[67]  S. McKnight,et al.  An interleukin-4-induced transcription factor: IL-4 Stat. , 1994, Science.

[68]  M. Greene,et al.  Intermolecular association of the p185 neu protein and EGF receptor modulates EGF receptor function , 1990, Cell.

[69]  M. Ultsch,et al.  Crystals of the complex between human growth hormone and the extracellular domain of its receptor. , 1991, Journal of molecular biology.

[70]  S. Corey,et al.  Granulocyte colony-stimulating factor receptor signaling involves the formation of a three-component complex with Lyn and Syk protein-tyrosine kinases. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[71]  K. Arai,et al.  Signal transduction by the high‐affinity GM‐CSF receptor: two distinct cytoplasmic regions of the common beta subunit responsible for different signaling. , 1993, The EMBO journal.

[72]  M. Preece,et al.  A single amino acid substitution in the exoplasmic domain of the human growth hormone (GH) receptor confers familial GH resistance (Laron syndrome) with positive GH‐binding activity by abolishing receptor homodimerization. , 1994, The EMBO journal.

[73]  A. Ullrich,et al.  Stabilization of an active dimeric form of the epidermal growth factor receptor by introduction of an inter-receptor disulfide bond. , 1994, The Journal of biological chemistry.

[74]  B. Groner,et al.  Prolactin induces phosphorylation of Tyr694 of Stat5 (MGF), a prerequisite for DNA binding and induction of transcription. , 1994, The EMBO journal.

[75]  J. Darnell,et al.  Interferon-dependent tyrosine phosphorylation of a latent cytoplasmic transcription factor. , 1992, Science.

[76]  L. Claesson-Welsh,et al.  Platelet-derived growth factor receptor signals. , 1994, The Journal of biological chemistry.

[77]  S. Cohen,et al.  Induction by EGF and interferon-gamma of tyrosine phosphorylated DNA binding proteins in mouse liver nuclei. , 1993, Science.

[78]  川原 敦雄 Evidence for a critical role for the cytoplasmic region of the interleukin 2 (IL-2) receptor γ chain in IL-2, IL-4, and IL-7 signalling , 1995 .

[79]  Y. Yarden,et al.  Epidermal growth factor induces rapid, reversible aggregation of the purified epidermal growth factor receptor. , 1987, Biochemistry.

[80]  J. Darnell,et al.  Activation of transcription by IFN-gamma: tyrosine phosphorylation of a 91-kD DNA binding protein. , 1992, Science.

[81]  G. Ciliberto,et al.  Generation of interleukin‐6 receptor antagonists by molecular‐modeling guided mutagenesis of residues important for gp130 activation. , 1994, The EMBO journal.

[82]  P. Phillips,et al.  Two different subunits associate to create isoform-specific platelet-derived growth factor receptors. , 1989, The Journal of biological chemistry.

[83]  T. Hunter,et al.  Protein kinases and phosphatases: The Yin and Yang of protein phosphorylation and signaling , 1995, Cell.

[84]  岡留 敏秀 Distinct roles of the intracellular domains of transforming growth factor-β type I and type II receptors in signal transduction , 1996 .

[85]  Y. Yarden,et al.  Cell‐type specific interaction of Neu differentiation factor (NDF/heregulin) with Neu/HER‐2 suggests complex ligand‐receptor relationships. , 1993, The EMBO journal.

[86]  T Pawson,et al.  Ligands for EPH-related receptor tyrosine kinases that require membrane attachment or clustering for activity. , 1994, Science.

[87]  C. Kahn,et al.  A cascade of tyrosine autophosphorylation in the beta-subunit activates the phosphotransferase of the insulin receptor. , 1988, The Journal of biological chemistry.

[88]  宮崎 忠昭 Functional activation of Jak1 and Jak3 by selective association with IL-2 receptor subunits , 1995 .

[89]  M. Fellous,et al.  A protein tyrosine kinase in the interferon α β signaling pathway , 1992, Cell.

[90]  G. Plowman,et al.  Heregulin induces tyrosine phosphorylation of HER4/p180erbB4 , 1993, Nature.

[91]  T. Pawson,et al.  Nuclear magnetic resonance structure of an SH2 domain of phospholipase C-γ1 complexed with a high affinity binding peptide , 1994, Cell.

[92]  K. Miyazono,et al.  Distinct roles of the intracellular domains of transforming growth factor-beta type I and type II receptors in signal transduction. , 1994, The Journal of biological chemistry.

[93]  B. Seed,et al.  Cellular immunity to HIV activated by CD4 fused to T cell or Fc receptor polypeptides , 1991, Cell.

[94]  W. Fantl,et al.  Signalling by receptor tyrosine kinases. , 1993, Annual review of biochemistry.

[95]  W. Gullick,et al.  Identification of c‐erbB‐3 binding sites for phosphatidylinositol 3′‐kinase and SHC using an EGF receptor/c‐erbB‐3 chimera. , 1994, The EMBO journal.

[96]  A. Weiss,et al.  Sequential interactions of the TCR with two distinct cytoplasmic tyrosine kinases. , 1994, Science.

[97]  C. Heldin,et al.  Dimerization of B-type platelet-derived growth factor receptors occurs after ligand binding and is closely associated with receptor kinase activation. , 1989, The Journal of biological chemistry.

[98]  M. F. Shannon,et al.  Specific human granulocyte-macrophage colony-stimulating factor antagonists. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[99]  A. DeFranco,et al.  B-cell antigen receptor motifs have redundant signalling capabilities and bind the tyrosine kinases PTK72, Lyn and Fyn , 1993, Current Biology.

[100]  M. Eisenstein,et al.  The fourth immunoglobulin domain of the stem cell factor receptor couples ligand binding to signal transduction , 1995, Cell.

[101]  G. Stark,et al.  The protein tyrosine kinase JAK1 complements defects in interferon-α/β and -γ signal transduction , 1993, Nature.

[102]  R. Perlmutter,et al.  Interaction of the IL-2 receptor with the src-family kinase p56lck: identification of novel intermolecular association , 1991, Science.

[103]  L. Cantley,et al.  ErbB3 is involved in activation of phosphatidylinositol 3-kinase by epidermal growth factor , 1994, Molecular and cellular biology.

[104]  J. Bazan,et al.  Structural design and molecular evolution of a cytokine receptor superfamily. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[105]  J. Darnell,et al.  A common nuclear signal transduction pathway activated by growth factor and cytokine receptors. , 1993, Science.

[106]  J. Kuriyan,et al.  Binding of a high affinity phosphotyrosyl peptide to the Src SH2 domain: Crystal structures of the complexed and peptide-free forms , 1993, Cell.

[107]  K. Miyazono,et al.  Formation of hetero-oligomeric complexes of type I and type II receptors for transforming growth factor-beta. , 1994, The Journal of biological chemistry.

[108]  T. Taniguchi,et al.  Evidence for a critical role for the cytoplasmic region of the interleukin 2 (IL-2) receptor gamma chain in IL-2, IL-4, and IL-7 signalling , 1994, Molecular and cellular biology.

[109]  M. Kraus,et al.  Efficient coupling with phosphatidylinositol 3-kinase, but not phospholipase C gamma or GTPase-activating protein, distinguishes ErbB-3 signaling from that of other ErbB/EGFR family members , 1994, Molecular and cellular biology.

[110]  C. Cooper,et al.  Mechanism of met oncogene activation , 1986, Cell.

[111]  B. Viviano,et al.  Ligand‐induced IFN gamma receptor tyrosine phosphorylation couples the receptor to its signal transduction system (p91). , 1994, The EMBO journal.

[112]  T. Hirano,et al.  Interleukin-6 triggers the association of its receptor with a possible signal transducer, gp130 , 1989, Cell.

[113]  D. Weiner,et al.  A point mutation in the neu oncogene mimics ligand induction of receptor aggregation , 1989, Nature.

[114]  D. Goeddel,et al.  A novel family of putative signal transducers associated with the cytoplasmic domain of the 75 kDa tumor necrosis factor receptor , 1994, Cell.

[115]  J. Ravetch Fc receptors: Rubor redux , 1994, Cell.

[116]  J. Darnell,et al.  Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. , 1994, Science.